Alice Pomponio

Cancer-Fighting Biotech to Move Research Operations to Dallas After ACS ‘Golden Ticket’ Win

by | Mar 24, 2025
Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
MORE►
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE►
Lyda Hill Philanthropies Makes $5.25M Gift to American Cancer Society Venture Capital Arm
by | Nov 6, 2023
The gift, the largest to date for BrightEdge, will fund a "first-of-its-kind program" called the ACS BrightEdge Texas Accelerator. The two-year pilot innovation program will invest in cutting-edge companies making headway in the fight to eliminate cancer.
MORE►